- About CSAM
- Public Policy
Webinars and Online Education
Webinar: Clearing the Air: Marijuana's Effect on Health
Posted July 29, 2014. Valid through July 28, 2017.
Changes in the public perception of marijuana have contributed to profound changes in drug policy and enforcement, as well as significant changes in availability of marijuana products. Dr. Danovitch's presentation will provide a review of recent findings on marijuana with an emphasis on addressing questions patients frequently ask their physicians about its use, and based on up-to-date science, suggest ways to improve physician-patient discussions about cannabis and apply them to a clinical setting.
Presenter: Itai Danovitch, MD
Dr. Danovitch is President of the California Society of Addiction Medicine, and Chair for the Department of Psychiatry and Director of Addiction Psychiatry at Cedars Sinai Medical Center. His research interests have focused on substance use disorders, particularly marijuana, as well as the integration of medical and mental health services.
Webinar: Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin and Combined User
Recorded February 5, 2014. Valid for CME through December 31, 2016
Jennifer Sharpe Potter, Ph.D., M.P.H.
Associate Professor in the Departments of Psychiatry and Anesthesiology and Assistant Dean for Research and Student Programs in the School of Medicine at the University of Texas Health Science Center San Antonio.
This webinar enables physicians to improve their knowledge and patient practices with respect to treatment recommendations for opioid analgesic (OA), heroin, and combined users through opioid replacement therapy (ORT). The webinar will present findings from the "Starting Treatment With Agonist Replacement Therapies (START)" study. Physicians will learn about the differences in both methadone and buprenorphine treatment outcomes for heroin versus OA users and injectors versus non-injectors.
Webinar: Naloxone for Opioid Safety: A Tool in California for Saving Lives
Recorded March 27, 2014. Valid for CME through December 31, 2016
Phillip Coffin, MD, Director of Substance Use Research at the San Francisco Department of Public Health
Eliza Wheeler, MA, MS, Drug Overdose Prevention and Education Project (DOPE), San Francisco
On January 1, 2014, the Overdose Treatment Act, became law in California. It allows lay people to possess and administer prescription naloxone to someone in urgent need who is experiencing life-threatening respiratory depression from excessive opiate use. Doctors may provide the prescription to the intended patient, a friend, family member, health care worker, or to a member of the community at large without even having met the intended recipient. Both the doctor and the lay person receive legal protection. Naloxone is a nonscheduled, non-addictive, safe, and inexpensive prescription medication which is becoming available in pharmacies throughout the state in nasal spray and injectable forms. To learn how to use it safely requires minimal instruction
- Talking About Naloxone in a Primary Care or Pain Management Setting Presented by Phillip Coffin, MD Director of Substance Use Research at the San Francisco Department of Public Health
- Talking About Naloxone in a Substance Abuse Treatment Setting Presented by Eliza Wheeler, MA, MS Drug Overdose Prevention and Education Project (DOPE), San Francisco
- Inside the "Naloxone Kit" Presented by Eliza Wheeler, MA, MS Drug Overdose Prevention and Education Project (DOPE), San Francisco
and additional resources.
Online Journal Club
- Article: Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)
This article documents differences in the clinical characteristics of individuals with opioid dependence as opioid use varies by type and route. It should enable you to discuss the potentially important factors that may be associated with clinical outcomes of opioid replacement therapy (ORT) with your patients. Published in the Journal of Studies on Alcohol and Drugs, July 2013.
- Article: Persistent cannabis users show neuropsychological decline from childhood to midlife.
This article documents differences in levels of neuropsychological decline for those who begin heavy and regular marijuana use in adolescence. It should enable you to discuss the latest evidence on effects of marijuana use in adolescents with your patients. Published in the Proceedings of the National Academy of Sciences (PNAS). Submitted for publication April 2012
Addiction Medicine State of the Art 2013
This online course provides video recordings of the 2013 Addiction Medicine State of the Art Conference, held on October 17-19, 2013. The 3-day Conference presents an overview of the latest developments in the field and their relevance to clinical practice presented by top experts in the field. Learners can receive up to 15 AMA PRA Category 1 Credits™ Participants can view the lectures at their own pace. If learners prefer to only complete some events, they can do so and print your certificate at any time. In addition to the video/Powerpoint presentations, participants can download PDF and MP3 audio of all talks.
Addiction Medicine Review Course and ABAM Certification Exam Preparation Track (2012)
The online Review Course consists of 23 lectures providing an overview of the core elements of addiction medicine, presented by top experts in the field. It can serve as a broad review for clinicians in practice, a review of the basics of the field for new-comers or a starting point for self-assessment and study for those planning to sit for the ABAM Addiction Medicine Boards exams. Participants can view the lectures at their own pace. If learners prefer to only complete some events, they can do so and print your certificate at any time. In addition to the video/Powerpoint presentations, participants can download PDF and MP3 audio of all talks.
Presentations from Addiction Medicine State of the Art 2011
Available for viewing. CME credit not available.
Other Online Addiction Medicine Related Education
Other recommended online CME